WntResearch submits patent application for novel methods of measuring biological effects of the company’s drug candidate Foxy-5
WntResearch has applied for a patent on two novel methods to measure biological effects in humans of the company’s Wnt-5a-agonist drug candidate Foxy-5. These method also have the potential to detect the effects of the company’s second drug candidate Box-5, a Wnt-5a-antagonist. The methods facilitate the drug candidates’ development and will be used for the evaluation of the company’s drug candidate Foxy-5 in current and future clinical studies, which is deemed to be of great importance for the future development of this potential treatment for metastasization of tumours. Professor Tommy